DC Investments Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
VCM
VPM
DC Investments Management's PFE Position: Q1 2026 in Review
DC Investments Management opened a new position in Pfizer (PFE) in Q1 2026: 7,128 shares worth $200K. The stake represents 0.08% of the portfolio and ranks #75 among its holdings. This is a return to the name: DC Investments Management previously reported a position in PFE as recently as Q3 2020.
DC Investments Management first reported a position in PFE in Q4 2017 and has held it in 13 quarters since. The position peaked at $2.99M in Q1 2018. 2,939 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- DC Investments Management held 7,128 shares of Pfizer worth $200K as of Q1 2026.
- Pfizer was a new DC Investments Management position in Q1 2026.
- Pfizer made up 0.08% of DC Investments Management's portfolio in Q1 2026, its #75 holding.
- DC Investments Management first reported a position in Pfizer in Q4 2017 and has held it in 13 quarters since.
- DC Investments Management's Pfizer position peaked at $2.99M in Q1 2018.
- 2,939 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on DC Investments Management's 13F filing for Q1 2026, filed 14 May 2026.